October 30, 2020 In a second big setback for C
Post# of 148166
(Total Views: 930)
Posted On: 10/30/2020 4:21:14 PM
October 30, 2020
In a second big setback for Covid-19 antibody treatment hopes, Regeneron halts enrollment for more severe patients
"The news comes a week after the NIH scrapped a trial of Eli Lilly’s Covid-19 antibody after finding it was having little effect on an initial cohort of hospitalized patients.
..enrollment will continue for patients hospitalized with Covid-19 who either don’t require oxygen or require low-flow oxygen."
https://endpts.com/in-a-second-big-setback-fo...-patients/
In a second big setback for Covid-19 antibody treatment hopes, Regeneron halts enrollment for more severe patients
"The news comes a week after the NIH scrapped a trial of Eli Lilly’s Covid-19 antibody after finding it was having little effect on an initial cohort of hospitalized patients.
..enrollment will continue for patients hospitalized with Covid-19 who either don’t require oxygen or require low-flow oxygen."
https://endpts.com/in-a-second-big-setback-fo...-patients/
(3)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼